FDA Investigator Patrick D Stone, MS

Patrick D Stone, MS has conducted inspections on 251 sites in 8 countries as of 28 Feb 2011. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
251
Last Inspection Date:
28 Feb 2011
Investigator Role:
FDA Investigator
Redica ID:
100002711
Countries of Inspections:
United States of America, Denmark, Canada, Germany, Argentina, Mexico, Brazil, Hungary
FDA Investigators that have inspected at least one site in common with Patrick D Stone, MS:
Adam C Hipko, Alanna L Mussawwir Bias, Albert F Peacock, PhD, Amanda J White, Andrace L Deyampert, Andrea A Branche, Anh M Lac, Anthony E Keller, RPh, Anya Dlockett Evans, Arindam Dasgupta, PhD, Ashley N Williams, Audrey J Yarbrough, Barbara J White, Benjamin K Kingsley, Betsy C Galliher, Bing Lin, Blondell W Johnson, Bonita S Chester, Brackens Harris, Brian Sanders, Byungja E Marciante, Camerson E Moore, Camille D Brown, Carla J Lundi, Carol A Declouette Wilburn, Carol Rivera Lopez, PhD, Charles B Steinmiller, Charles D Brown, Christopher D Rush, Christopher J Hurst, Claire M Minden, Constance M Dobbins, Cynthia A Harris, MD, RN, Cynthia F Kleppinger, MD, Daniel J Lahar, Daniel S Fam, Daniell Gill, Jr, Danielle Lyke, Darla J Christopher, David M Beltran, Deniza Karacic, Diane Cvan Leeuwen, Dr. Jason R Caballero, Dr. Sriram Subramaniam, PhD, Ed Gonzalez Vazquez, Edward D Mcdonald, Elisa M Fleming, Elizabeth Ad Girard, Elizabeth D Connell, Ellen J Tave, Elvia J Cervantes, Erin L Mcfiren, Ernest Serna, III, Francis A Guidry, Frans E Mercado, Gajendiran Mahadevan, PhD, George C Amedro, George J Flynn, Gerald N Mcgirl, DDS, Geraldine D Sanders, Grant L Davis, Habacuc V Barrera, Hugh M Mcclure, II, Hung V Le, Iris C Macinnes, J Elkins, Jacqueline A O'shaughnessy, PhD, James H Robinson, James M Kewley, James P Stumpff, Jeffrey R Wooley, Jeffrey W Shrifter, DPM, Jennifer L Sheehan, Jennifer O Dowdy, Jocelyn C Turner, Jodi M Gatica, Joel D Martinez, Johann M Fitch, John A Kadavil, PhD, John Ahearn, Joseph B Carballa, Joy L Ramsey, Kamara Tx, Kara A Scheibner, PhD, Karen C Daugherty, Kari M Johansen, Karlton T Watson, Katherine Szestypalow, Kathleen B Swat, Kevin T Nguyen, L Grant, Lan T Tran, Latorie S Jones, Lauren E Skokan, Leighton Kn Gai, Lillie M Young, Lisa M Pence, Lisa M Puttonen, Lisa R Whitt, Lloyd D Payne, Lourdes R Genera, Lowell R Oates, Lucas B Leake, Luis E Gonzalez, Maira P Brading, Margaret M Annes, Mark A Guerra, Mark C Flotte, Martha S Baldwin, Martin K Yau, PhD, Mary R Reed, Melkamu Getie Kebtie, PhD, Michael F Skelly, PhD, Michael P Sheehan, Mildred H Glasgow, Monique Rac Lester, Nancy A Bellamy, Nilufer M Tampal, PhD, Patricia M Jacobs, Patrick J Mcneilly, Paul E Frazier, Paula J Perry, Paulene M Wohlgemuth, Pitman, Rebecca C O'bryan, Rebecca Co Bryan, Rene R Ramirez, Richard T Riggie, Robert Barron, Robert D Tollefsen, Robert L Lewis, Jr, Robert T Lorenz, Ronda Rloyd Jones, Ronnie Garza, Rose Ashley, Roy R Rinc, Ruth E Medcalf, Sam H Haidar, PhD, Samantha J Pinizzotto, D V M, Sandra A Hughes, Scott T Ballard, Sha'tina R Alridge, Sharon K Thoma, PharmD, Shawn E Larson, Sina Shojaee, Srinivas R Chennamaneni, PhD, Sripal R Mada, PhD, Staci G Mcallister, Stephanie D Crockett, Stephen D Brown, Steven Eastham, Steven L Strom, Suzanne G Demko, Sylvia E Gaytan, Tara A Gray, Terrance L Thomas, Thomas J Arista, Timothy H Vo, Toby Vern H Hill, Torrance J Slayton, Travis M Beard, Tricia S Martinez, Tricia Y Samaniego, Trina K Vick, Trinidad D Barreras, Unnee Ranjan, Verlinda A Narcisse, Vickie J Kanion, Xikui Chen (nmi), PhD, Yaw O Osei, Young M Yoon, Yvette Mlacour Davis, Zachary L Miller, Zerita White

Patrick D Stone, MS's Documents

Publish Date Document Type Title
November, 2004 FDA 483 Massimo Cristofanilli, MD - Form 483, 2004-11-03
March, 2002 EIR Merrick I Ross, MD - EIR, 2002-03-28
February, 2000 EIR Jorg J Pahl, MD - EIR, 2000-02-25
November, 2008 FDA 483 Gonzalez, Anneliese, M.D. - Form 483, 2008-11-20
October, 2004 FDA 483 UT MD Anderson Cancer Center RDRC - Form 483, 2004-10-22
February, 2001 EIR Jonathan R L Schwartz, Md/CIin Inv - EIR, 2001-02-15
January, 2001 EIR Adaani E Frost, MD, PI - EIR, 2001-01-25
February, 2000 EIR William Insull, Jr, Md/Clin Inv - EIR, 2000-02-07
May, 2010 FDA 483 Cetero Research - Form 483, 2010-05-07
January, 2000 EIR Michael D Lesem, MD/Clin Inv - EIR, 2000-01-20
June, 2000 EIR Charles T Van Buren, MD/Clin Inv - EIR, 2000-06-20
January, 2003 EIR Matthew N. Brams, M.D., CI - EIR, 2003-01-22
August, 2006 EIR Jerry Mitchell - EIR, 2006-08-17
February, 2002 EIR BRI Institutional Review Board, Inc. - EIR, 2002-02-15
February, 2002 FDA 483 BRI Institutional Review Board, Inc. - Form 483, 2002-02-15
November, 2004 EIR Massimo Cristofanilli, MD - EIR, 2004-11-03
December, 2008 FDA 483 BRI Institutional Review Board, Inc. - Form 483, 2008-12-10
November, 2004 FDA 483 MD Anderson Cancer Center - Form 483, 2004-11-02
August, 2001 FDA 483 Stanislaw R Burzynski, MD - Form 483, 2001-08-10
April, 2010 EIR Stillmeadow Incorporated - EIR, 2010-04-28
December, 2000 EIR Issam I Raad, MD/Clin Inv - EIR, 2000-12-13
January, 2004 EIR NUVISAN GmbH - EIR, 2004-06-02
September, 2000 FDA 483 S.R. Burzynski Manufacturing Facility - Form 483, 2000-09-13
August, 2005 FDA 483 Christopher J. Logothetis, MD, PI - Form 483, 2005-08-05
October, 2005 EIR Adaani E Frost, MD, PI - EIR, 2005-10-21
February, 2002 EIR Michael D Lesem, MD/Clin Inv - EIR, 2002-02-28
June, 2000 EIR Aman Buzdar, Md/Clinv - EIR, 2000-06-07
August, 2000 EIR Monica W Thint, MD/Clin Inv - EIR, 2000-08-10
April, 2007 EIR Altasciences Company Inc. - EIR, 2007-05-23
August, 2006 EIR Oscar "Howard" Frazier - EIR, 2006-08-31
November, 2004 EIR MD Anderson Cancer Center - EIR, 2004-11-02
January, 2005 FDA 483 Response Janet Lowther, BS, CI - Form 483R, 2005-01-28
March, 2005 FDA 483 PharMedium Services, Llc - Form 483, 2005-03-31
January, 2005 FDA 483 Janet Lowther, BS, CI - Form 483, 2005-01-14
April, 2007 EIR Altasciences Company Inc. - EIR, 2007-05-23
December, 2004 FDA 483 Farouk Systems, Inc. - Form 483, 2004-11-23
December, 2002 EIR Adelaide A Hebert, MD Clin Inv - EIR, 2002-12-20
January, 2005 EIR Janet Lowther, BS, CI - EIR, 2005-01-14

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more